In addition, an increased ratio of NK cells to LOX-1+ PMN-MDSC predicted positive therapy response of patients with non-small cell lung carcinoma, indicating an important role of NK cell inhibition by PMN-MDSC in tumor progression [50]. This evidence concerns the gene OLR1 and non-small cell lung carcinoma.